HIF1A and neoplasm: Thus, targeting lactate derived from tumor cells and the hypoxia-inducible factor-1α (HIF-1α) signaling in MDSCs could reinstate antitumor T-cell responses and inhibit tumor progression after radiotherapy in pancreatic cancer, indicating distinct promise for clinical therapies to alleviate radio resistance in PDAC.